CLDX vs ESTA: Which Stock Is the Better Buy?
Celldex Therapeutics, Inc. and Establishment Labs Holdings Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — CLDX vs ESTA, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Celldex Therapeutics, Inc. (CLDX) | Establishment Labs Holdings Inc. (ESTA) | |
|---|---|---|
| Market cap | $2.3B | $2.4B |
| Revenue (latest FY) | $1.54M | $211.08M |
| Net income (latest FY) | $-258.76M | $-51.06M |
| Revenue growth (5y CAGR) | -26.9% | 20.0% |
| Net margin | -16748.0% | -24.2% |
| Return on equity | -49.1% | -216.9% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | No | No |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full CLDX vs ESTA breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open CLDX's full financials → Open ESTA's full financials →More comparisons
Frequently asked questions
Which is bigger, CLDX or ESTA?
Establishment Labs Holdings Inc. is larger by market capitalization — $2.4B versus $2.3B.
Which grows faster, CLDX or ESTA?
Over the last five fiscal years, Establishment Labs Holdings Inc. grew revenue faster — 20.0%/yr versus -26.9%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
CLDX fundamentals → · ESTA fundamentals → · All 1,500+ companies → · Free screener →